Tandem Diabetes Care (TNDM) Finished Goods (2014 - 2019)

Tandem Diabetes Care's Finished Goods history runs 6 years deep, the most recent figure standing at $9.7 million for Q1 2019.

• Quarterly Finished Goods fell 21.48% year-over-year to $9.7 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $9.7 million (down 21.48% YoY) and the FY2018 annual result came in at $10.6 million, down 17.81% from the prior year.
• Finished Goods was $9.7 million for Q1 2019 at Tandem Diabetes Care, down from $10.6 million in the prior quarter.
• Across five years, Finished Goods topped out at $14.4 million in Q3 2017 and bottomed at $2.9 million in Q2 2015.
• A 5-year average of $8.5 million and a median of $9.1 million in 2016 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2016 — Finished Goods surged 145.5% — and 2019, when it fell 21.48%.
• Tandem Diabetes Care's Finished Goods stood at $3.5 million in 2015, then jumped by 109.57% to $7.4 million in 2016, then surged by 73.1% to $12.9 million in 2017, then dropped by 17.81% to $10.6 million in 2018, then decreased by 8.36% to $9.7 million in 2019.
• Business Quant data shows TNDM's Finished Goods at $9.7 million in Q1 2019, $10.6 million in Q4 2018, and $11.3 million in Q3 2018.